Principia Wealth Advisory’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.32K Sell
12
-156
-93% -$87.5K ﹤0.01% 312
2026
Q1
$94.4K Buy
168
+27
+19% +$17.3K 0.05% 113
2025
Q4
$95.4K Buy
141
+81
+135% +$55.2K 0.06% 110
2025
Q3
$38.3K Buy
60
+56
+1,400% +$34K 0.03% 135
2025
Q2
$2.15K Buy
4
+1
+33% +$478 ﹤0.01% 368
2025
Q1
$1.19K Buy
3
+2
+200% +$868 ﹤0.01% 361
2024
Q4
$413 Buy
+1
New +$439 ﹤0.01% 598

Other funds holding IDXX

Principia Wealth Advisory's IDXX Position: Q2 2026 in Review

Principia Wealth Advisory reduced its Idexx Laboratories (IDXX) stake by 93% in Q2 2026, selling an estimated $87.5K and leaving 12 shares worth $6.32K. The position accounts for ﹤0.01% of the portfolio, ranked #312.

Principia Wealth Advisory first reported a position in IDXX in Q4 2024 and has held it in 7 quarters since. The position peaked at $95.4K in Q4 2025. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Principia Wealth Advisory held 12 shares of Idexx Laboratories worth $6.32K as of Q2 2026.
  • Principia Wealth Advisory sold 156 Idexx Laboratories shares in Q2 2026, an estimated $87.5K.
  • Idexx Laboratories made up ﹤0.01% of Principia Wealth Advisory's portfolio in Q2 2026, its #312 holding.
  • Principia Wealth Advisory first reported a position in Idexx Laboratories in Q4 2024 and has held it in 7 quarters since.
  • Principia Wealth Advisory's Idexx Laboratories position peaked at $95.4K in Q4 2025.
  • 1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Principia Wealth Advisory's 13F filing for Q2 2026, filed 26 Aug 2026.